- MHE April 2026
- Volume 36
- Issue 4
The future of pharmacy: What the MHE 2026 Pharmacy Survey signals for the year ahead
The 2026 MHE Pharmacy Survey asked questions about most-favored nation drug pricing, PBM reform and HHS Secretary Robert F. Kennedy Jr.'s vaccine policies. Respondents rated direct-to-consumer drug sales by drugmaker as the most important development in the pharmaceutical sector this year.
As the role of pharmaceuticals continues to expand across the healthcare ecosystem, stakeholders are navigating a landscape increasingly shaped by rising specialty drug costs, evolving policy pressures and ongoing scrutiny of pricing and reimbursement models. To better understand these dynamics, Managed Healthcare Executive conducted its annual Pharmacy survey, capturing perspectives from payers, pharmacy leaders, health systems, academic institutions, government and pharmacy benefit managers (PBMs). To help contextualize what these changes mean for the future of care delivery and cost management, we invited three experts to share their thoughts.